Search Results for Highly Active Antiretroviral Therapy.html

Data from University of California Provide New Insights into HAART

2012 MAY 23 ... at 62 per 1,000 person-years, the incidence of AKI declined after the introduction of highly active antiretroviral therapy (HAART) in 1996 to a low point of 25 per 1,000 ... per 1,000 person-years, the incidence of AKI declined after the introduction of highly active antiretroviral therapy (HAART) in 1996 to a low point of 25 per 1,000 person-years ... person-years, the incidence of AKI declined after the introduction of highly active antiretroviral therapy (HAART) in 1996 to a low point of 25 per 1,000 person-years in ...

Subject: HAART

Data on HAART Detailed by Researchers at University of Pennsylvania

2012 MAY 25 ... in MV1 and 1.06 (0.99-1.14) in MV2. Among patients entering the cohort in the highly active antiretroviral therapy (HAART) era (n = 32 439), TDF exposure was ... in MV1 and 1.06 (0.99-1.14) in MV2. Among patients entering the cohort in the highly active antiretroviral therapy (HAART) era (n = 32 439), TDF exposure was associated with ... and hepatitis C status) and model 2 (MV2 - controlling for MV1 variables + concomitant antiretroviral exposures). Among 56 660 patients evaluated, TDF exposure (total 46 062 ...

Subject: HAART

Investigators at University of Pittsburgh Discuss Research in HIV/AIDS

2012 MAY 23 ... parameters of liver function, HIV and HCV viral loads, CD4+ cell counts, and data on highly active antiretroviral therapy (HAART) were recorded. Cardiovascular disease risk ... of liver function, HIV and HCV viral loads, CD4+ cell counts, and data on highly active antiretroviral therapy (HAART) were recorded. Cardiovascular disease risk was ... of liver function, HIV and HCV viral loads, CD4+ cell counts, and data on highly active antiretroviral therapy (HAART) were recorded. Cardiovascular disease risk was evaluated ...

Subject: HIV/AIDS

New Data from Gadjah Mada University Illuminate Research in HIV/AIDS

2012 MAY 23 ... liver disease increases substantially the mortality rate of patients with HIV on highly active antiretroviral therapy (HAART). Therefore, early diagnosis of hepatitis B ... liver disease increases substantially the mortality rate of patients with HIV on highly active antiretroviral therapy (HAART). Therefore, early diagnosis of hepatitis B virus ... disease increases substantially the mortality rate of patients with HIV on highly active antiretroviral therapy (HAART). Therefore, early diagnosis of hepatitis B virus (HBV) and ...

Subject: HIV/AIDS

New HIV/AIDS Research from V. Le Douce and Co-Researchers Described

2012 MAY 16 ... "The introduction of highly active antiretroviral therapy (HAART) in 1996 has transformed a lethal disease to ... "The introduction of highly active antiretroviral therapy (HAART) in 1996 has transformed a lethal disease to a ... "The introduction of highly active antiretroviral therapy (HAART) in 1996 has transformed a lethal disease to a chronic ...

Subject: HIV/AIDS

New HIV/AIDS Research Has Been Reported by Investigators at University of Auckland

2012 MAY 16 ... of short duration, typically 12 years. Some studies, especially of cohorts treated with highly active antiretroviral therapy (HAART), report short-term stable or increasing BMD, ... duration, typically 12 years. Some studies, especially of cohorts treated with highly active antiretroviral therapy (HAART), report short-term stable or increasing BMD, but ... typically 12 years. Some studies, especially of cohorts treated with highly active antiretroviral therapy (HAART), report short-term stable or increasing BMD, but other ...

Subject: HIV/AIDS

Research from University Hospital Reveals New Findings on HAART

2012 MAY 16 ... possibly related to HIV-infected patients who, despite being under suppressive highly active antiretroviral therapy (HAART), show low-level CD4 T cell repopulation ... possibly related to HIV-infected patients who, despite being under suppressive highly active antiretroviral therapy (HAART), show low-level CD4 T cell repopulation (LLR). ... related to HIV-infected patients who, despite being under suppressive highly active antiretroviral therapy (HAART), show low-level CD4 T cell repopulation (LLR). Twenty-one ...

Subject: HAART

Researchers at University of Cape Town Target HIV/AIDS

2012 MAY 21 ... outcomes, challenges in restarting optimal anti-tuberculosis therapy and the timing of highly active antiretroviral therapy initiation in those with HIV coinfection are also ... challenges in restarting optimal anti-tuberculosis therapy and the timing of highly active antiretroviral therapy initiation in those with HIV coinfection are also ... in restarting optimal anti-tuberculosis therapy and the timing of highly active antiretroviral therapy initiation in those with HIV coinfection are also discussed," ...

Subject: HIV/AIDS

Researchers at University of Nairobi Target HIV/AIDS

2012 MAY 23 ... services is complex, and attrition was usually high. There was a failure to initiate highly active antiretroviral therapy (HAART) among 38-88% of known-eligible women. ... is complex, and attrition was usually high. There was a failure to initiate highly active antiretroviral therapy (HAART) among 38-88% of known-eligible women. Providing ` ... complex, and attrition was usually high. There was a failure to initiate highly active antiretroviral therapy (HAART) among 38-88% of known-eligible women. Providing ` ...

Subject: HIV/AIDS

Researchers from Azienda Ospedaliera University Report Recent Findings in HAART

2012 MAY 23 ... 20 patients (group A) had experienced a hypersensitivity reaction when treated with highly active antiretroviral therapy (HAART) including ABC; 60 HIV-positive patients ... patients (group A) had experienced a hypersensitivity reaction when treated with highly active antiretroviral therapy (HAART) including ABC; 60 HIV-positive patients (group B) ... authors of recent research published in the journal Dermatologic Therapy, "The use of antiretroviral drug abacavir (ABC) has been often associated with cutaneous ...

Subject: HAART

Researchers from Catholic University of Leuven Report Details of New Studies and Findings in the Area of Herpes Simplex Virus

2012 MAY 21 ... or in combination with other drugs against HIV-1, especially to complement or delay highly active antiretroviral therapy (HAART) initiation in low-resource settings." ... in combination with other drugs against HIV-1, especially to complement or delay highly active antiretroviral therapy (HAART) initiation in low-resource settings." ... with other drugs against HIV-1, especially to complement or delay highly active antiretroviral therapy (HAART) initiation in low-resource settings." ...

Subject: Herpes Simplex Virus

Researchers from Christian Medical College Publish Findings in HIV/AIDS

2012 MAY 23 ... for lipodystrophy. Male patients between 25 and 50 years old with proven HIV infection (highly active antiretroviral therapy [HAART]-naive subjects and those receiving ... Male patients between 25 and 50 years old with proven HIV infection (highly active antiretroviral therapy [HAART]-naive subjects and those receiving successful ... Male patients between 25 and 50 years old with proven HIV infection (highly active antiretroviral therapy [HAART]-naive subjects and those receiving successful HAART) were ...

Subject: HIV/AIDS

Scientists at Eunice Kennedy Shriver National Institute of Child Health and Human Development Publish New Data on HIV/AIDS

2012 MAY 9 ... the report "Dyslipidemia in a cohort of HIV-infected Latin American children receiving highly active antiretroviral therapy. 'In order to describe the prevalence of ... "Dyslipidemia in a cohort of HIV-infected Latin American children receiving highly active antiretroviral therapy. 'In order to describe the prevalence of ... in a cohort of HIV-infected Latin American children receiving highly active antiretroviral therapy. 'In order to describe the prevalence of hypercholesterolemia and ...

Subject: HIV/AIDS

Studies from APHP Provide New Data on HIV/AIDS

2012 MAY 22 ... lymphocytosis syndrome, were actively looked for and excluded. Treatment with highly active antiretroviral therapy was effective; symptoms rapidly improved, serum ... interstitial nephritis with predominant plasmacytic infiltration in 2 patients with active human immunodeficiency virus 1 (HIV-1) infection. Clinical features included acute ... syndrome, were actively looked for and excluded. Treatment with highly active antiretroviral therapy was effective; symptoms rapidly improved, serum creatinine level ...

Subject: HIV/AIDS

Studies from Christian Medical College Add New Findings in the Area of HAART

2012 MAY 23 ... for lipodystrophy. Male patients between 25 and 50 years old with proven HIV infection (highly active antiretroviral therapy [HAART]-naive subjects and those receiving ... Male patients between 25 and 50 years old with proven HIV infection (highly active antiretroviral therapy [HAART]-naive subjects and those receiving successful ... Male patients between 25 and 50 years old with proven HIV infection (highly active antiretroviral therapy [HAART]-naive subjects and those receiving successful HAART) were ...

Subject: HAART

Studies from F. Rangwala et al Further Understanding of HIV/AIDS

2012 MAY 21 ... presentation and laboratory findings that were reported mainly in the era prior to highly active antiretroviral therapy. We conducted a retrospective review at two ... and laboratory findings that were reported mainly in the era prior to highly active antiretroviral therapy. We conducted a retrospective review at two hospitals in ... and laboratory findings that were reported mainly in the era prior to highly active antiretroviral therapy. We conducted a retrospective review at two hospitals in Central ...

Subject: HIV/AIDS

Studies from University of Paris Add New Findings in the Area of HIV/AIDS

2012 MAY 9 ... Asia, and Australia to assess multidimensional quality of life impairments in the era of highly active antiretroviral therapy." "A cross-sectional study was ... Australia to assess multidimensional quality of life impairments in the era of highly active antiretroviral therapy." "A cross-sectional study was performed in ... to assess multidimensional quality of life impairments in the era of highly active antiretroviral therapy." "A cross-sectional study was performed in 8 ...

Subject: HIV/AIDS

Study Data from Vita Salute University Update Knowledge of HIV/AIDS and Kaposi Sarcoma

2012 MAY 23 ... In the case of ADM, survival was more favorable when cancer was diagnosed during post-highly active antiretroviral therapy (HAART) era (10-year survival: 43.2% +/- 4.4%) than ... case of ADM, survival was more favorable when cancer was diagnosed during post-highly active antiretroviral therapy (HAART) era (10-year survival: 43.2% +/- 4.4%) than when ... of ADM, survival was more favorable when cancer was diagnosed during post-highly active antiretroviral therapy (HAART) era (10-year survival: 43.2% +/- 4.4%) than when diagnosed ...

Subject: HIV/AIDS and Kaposi Sarcoma

Study Results from University of Modena and Reggio Emilia Broaden Understanding of Heart Attack

2012 MAY 9 ... "Highly active antiretroviral therapy (HAART) dramatically reduces human immunodeficiency ... "Highly active antiretroviral therapy (HAART) dramatically reduces human immunodeficiency virus ... "Highly active antiretroviral therapy (HAART) dramatically reduces human immunodeficiency virus ...

Subject: Heart Attack

University of Missouri Publishes Research in HAART

2012 MAY 9 ... "Neurocognitive impairment remains prevalent in HIV-infected (HIV+) individuals despite highly active antiretroviral therapy (HAART). We assessed the impact of HIV, HAART, and ... impairment remains prevalent in HIV-infected (HIV+) individuals despite highly active antiretroviral therapy (HAART). We assessed the impact of HIV, HAART, and aging ... impairment remains prevalent in HIV-infected (HIV+) individuals despite highly active antiretroviral therapy (HAART). We assessed the impact of HIV, HAART, and aging using ...

Subject: HAART